🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPharmacology & MechanismsGIP receptor pharmacology — my results so far Page 3

GIP receptor pharmacology — my results so far

DoseLogDan Mon, Jul 21, 2025 at 12:05 AM 12 replies 1,512 viewsPage 3 of 3
kate.chem
VIP Member
3,890
17,654
Dec 2023
California
Jul 21, 2025 at 10:16 PM#11
NurseKim_ATL said:
The pharmacokinetics explain nearly every practical question asked here.

Agreed, and the adaptation point cuts both ways: tachyphylaxis to gastric emptying is why tolerability improves, and it is also why people who were relying on physical fullness feel the effect fade while the appetite effect is still working.

Last edited: Jul 22, 2025 at 1:16 AM
39 12steve_okc, dave_SLC, FDA_TrackerJim and 36 others
Reply Quote Save Share Report
bbq_ray_KC
Member
378
1,678
Jul 2024
Kansas City, KS
Jul 22, 2025 at 8:10 AM#12
paul_denver said:
True, though the ladder is longer and that is not a neutral detail — six dose steps means six opportunities to stall on the way up, and plenty of…

Saving this. It is the first explanation that did not require me to already understand it. Sending this to two other people who asked me the same thing last week.

Last edited: Jul 22, 2025 at 10:10 AM
40 13MikeFit_NJ, InsuranceTom, WendyG_ATL and 37 others
Reply Quote Save Share Report
MikeNYC_runner
Member
378
1,678
Jul 2024
New York, NY
Jul 22, 2025 at 6:04 PM#13
NurseKim_ATL said:
The pharmacokinetics explain nearly every practical question asked here.

Pushing back on NurseKim_ATL here. This treats a plausible mechanism as a demonstrated one. Plausible is where you start looking, not where you stop.

Last edited: Jul 22, 2025 at 8:04 PM
41 14Dr.ObesityMed, HealthEcon_DC, PedsEndoPhilly and 38 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
Jul 23, 2025 at 3:58 AM#14

One concrete data point for the thread. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

42 15ricardo_MIA, BrianDallas92, labquiet_amy and 39 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jul 23, 2025 at 1:52 PM#15

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful.

43 16PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 40 others
Reply Quote Save Share Report

Similar Threads

GLP-1R desensitization — β-arrestin-mediated internalization18 replies
Biased agonism at GLP-1R — Gs vs β-arrestin signaling balance13 replies
Semaglutide albumin binding and the C-18 fatty acid linker17 replies
GIP receptor pharmacology — why GIP agonism enhances GLP-113 replies
Glucagon receptor signaling — hepatic glycogenolysis and lipolysis16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register